Successful Re-administration of Osimertinib in Osimertinib-induced Interstitial Lung Disease with an Organizing Pneumonia Pattern: A Case Report and Literature Review

Lignende værker

• Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (EGFR) Mutation with a History of Acquired Resistance to Osimertinib
  af: Makimoto, Go, et al.
  Udgivet: (2019)
• Managing Lung Cancer with Comorbid Interstitial Pneumonia
  af: Ichihara, Eiki, et al.
  Udgivet: (2019)
• Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression
  af: Nishii, Kazuya, et al.
  Udgivet: (2021)
• A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages
  af: Watanabe, Hiromi, et al.
  Udgivet: (2019)
• A case of axillary lymphadenitis caused by Mycobacterium intracellulare in an immunocompetent patient
  af: Itano, Junko, et al.
  Udgivet: (2019)